Olestra
Olestra (Olean)[edit]
Overview[edit]
Olestra, also known by its brand name Olean, is a synthetic fat substitute that contributes no calories to products. Developed to aid in the reduction of dietary fat intake, Olestra has been incorporated into the manufacturing of traditionally high-fat foods, such as potato chips, to decrease or completely remove their fat content. The Food and Drug Administration (FDA) granted approval for Olestra's use in the United States as an alternative to fats and oils in prepackaged ready-to-eat snacks in 1996. The FDA concluded that Olestra's use met the safety standards for food additives, providing a reasonable certainty of no harm to consumers.

History[edit]
Olestra was hailed as a revolutionary diet product in the 1990s, allowing consumers to enjoy their favorite snacks without the associated fat and calories. However, by the late 1990s, its popularity waned due to reported side effects. Despite this decline, Olestra-containing products can still be found in grocery stores in some countries, reflecting its continued but limited use.
Health Impacts[edit]
Benefits[edit]
Olestra allows for the consumption of lower-calorie versions of traditionally high-fat foods, potentially assisting in weight management and reducing the risk associated with high fat intake, such as heart disease.
Side Effects[edit]
The consumption of Olestra has been associated with various digestive side effects, including abdominal cramping, gas, and loose stools. Olestra can also inhibit the absorption of certain fat-soluble vitamins and nutrients, necessitating the fortification of Olestra-containing foods with these essential nutrients.

Regulatory Status[edit]
Initially approved by the FDA in 1996 for use in snack foods, Olestra's use has been subject to ongoing scrutiny due to its side effects. Despite this, it remains approved for use, with specific labeling requirements to inform consumers about the potential for vitamin loss and digestive side effects.
Current Use[edit]
While Olestra's presence in the market has significantly diminished since its peak popularity, it continues to be used in a select range of snack foods. Its use is more prevalent in certain regions, reflecting varying consumer preferences and regulatory environments.
See Also[edit]
References[edit]
External Links[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
